These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 10618102
61. Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis. Simpson IN, Finlay J, Winstanley DJ, Dewhurst N, Nelson JW, Butler SL, Govan JR. J Antimicrob Chemother; 1994 Sep; 34(3):353-61. PubMed ID: 7530242 [Abstract] [Full Text] [Related]
62. Phylogenetic study and multiplex PCR-based detection of Burkholderia plantarii, Burkholderia glumae and Burkholderia gladioli using gyrB and rpoD sequences. Maeda Y, Shinohara H, Kiba A, Ohnishi K, Furuya N, Kawamura Y, Ezaki T, Vandamme P, Tsushima S, Hikichi Y. Int J Syst Evol Microbiol; 2006 May; 56(Pt 5):1031-1038. PubMed ID: 16627650 [Abstract] [Full Text] [Related]
63. Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand. Kidd TJ, Douglas JM, Bergh HA, Coulter C, Bell SC. Res Microbiol; 2008 Apr; 159(3):194-9. PubMed ID: 18356026 [Abstract] [Full Text] [Related]
64. Outbreak of otitis media caused by Burkholderia gladioli infection in immunocompromised mice. Foley PL, Lipuma JJ, Feldman SH. Comp Med; 2004 Feb; 54(1):93-9. PubMed ID: 15027624 [Abstract] [Full Text] [Related]
65. Isolation from clinical sources of Burkholderia cepacia possessing characteristics of Burkholderia gladioli. Baxter IA, Lambert PA, Simpson IN. J Antimicrob Chemother; 1997 Feb; 39(2):169-75. PubMed ID: 9069537 [Abstract] [Full Text] [Related]
66. Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov. Vermis K, Coenye T, LiPuma JJ, Mahenthiralingam E, Nelis HJ, Vandamme P. Int J Syst Evol Microbiol; 2004 May; 54(Pt 3):689-691. PubMed ID: 15143009 [Abstract] [Full Text] [Related]
67. Burkholderia respiratory tract infections in Italian patients with cystic fibrosis: molecular characterization. Allice T, Scutera S, Chirillo MG, Savoia D. J Infect; 2006 Sep; 53(3):159-65. PubMed ID: 16375971 [Abstract] [Full Text] [Related]
68. In Vitro Activity of Ceftolozane-Tazobactam and Other Antimicrobial Agents against Burkholderia cepacia Complex and Burkholderia gladioli. Mazer DM, Young C, Kalikin LM, Spilker T, LiPuma JJ. Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674053 [Abstract] [Full Text] [Related]
69. SNaPBceBcon: a Practical Tool for Identification and Genotyping of Burkholderia cepacia and Burkholderia contaminans. Araujo R, Caramalho R, Coutinho C, Sá-Correia I. J Clin Microbiol; 2016 Feb; 54(2):483-8. PubMed ID: 26659211 [Abstract] [Full Text] [Related]
70. Flagellin gene PCR-RFLP analysis of a panel of strains from the Burkholderia cepacia complex. Winstanley C, Detsika MG, Glendinning KJ, Parsons YN, Hart CA. J Med Microbiol; 2001 Aug; 50(8):728-731. PubMed ID: 11478677 [Abstract] [Full Text] [Related]
71. Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. Gee JE, Sacchi CT, Glass MB, De BK, Weyant RS, Levett PN, Whitney AM, Hoffmaster AR, Popovic T. J Clin Microbiol; 2003 Oct; 41(10):4647-54. PubMed ID: 14532197 [Abstract] [Full Text] [Related]
72. Development of a recA gene-based identification approach for the entire Burkholderia genus. Payne GW, Vandamme P, Morgan SH, Lipuma JJ, Coenye T, Weightman AJ, Jones TH, Mahenthiralingam E. Appl Environ Microbiol; 2005 Jul; 71(7):3917-27. PubMed ID: 16000805 [Abstract] [Full Text] [Related]
73. [Phenotypic and genotypic characteristics of non fermenting atypical strains recovered from cystic fibrosis patients]. Ferroni A, Sermet-Gaudelus I, Abachin E, Quesnes G, Lenoir G, Berche P, Gaillard JL. Pathol Biol (Paris); 2003 Sep; 51(7):405-11. PubMed ID: 12948761 [Abstract] [Full Text] [Related]
74. Identification of Burkholderia cepacia complex pathogens by rapid-cycle PCR with fluorescent hybridization probes. Vonberg RP, Häußler S, Vandamme P, Steinmetz I. J Med Microbiol; 2006 Jun; 55(Pt 6):721-727. PubMed ID: 16687590 [Abstract] [Full Text] [Related]
75. Identification by subtractive hybridization of a novel insertion element specific for two widespread Burkholderia cepacia genomovar III strains. Liu L, Spilker T, Coenye T, LiPuma JJ. J Clin Microbiol; 2003 Jun; 41(6):2471-6. PubMed ID: 12791867 [Abstract] [Full Text] [Related]
76. Identification of Burkholderia cepacia Complex by PCR: A Simple Way. Dufour G, Lebel K, Bellemare J, Iugovaz I. PDA J Pharm Sci Technol; 2023 Dec 07; 77(6):485-497. PubMed ID: 37451835 [Abstract] [Full Text] [Related]
77. Growth in Stewart's medium is a simple, rapid and inexpensive screening tool for the identification of Burkholderia cepacia complex. Vanlaere E, Hansraj F, Vandamme PA, Govan JR. J Cyst Fibros; 2006 May 07; 5(2):137-9. PubMed ID: 16386966 [Abstract] [Full Text] [Related]
78. Development and evaluation of polymerase chain reaction assay to detect Burkholderia genus and to differentiate the species in clinical specimens. Suppiah J, Thimma JS, Cheah SH, Vadivelu J. FEMS Microbiol Lett; 2010 May 07; 306(1):9-14. PubMed ID: 20345378 [Abstract] [Full Text] [Related]
79. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center. Manno G, Dalmastri C, Tabacchioni S, Vandamme P, Lorini R, Minicucci L, Romano L, Giannattasio A, Chiarini L, Bevivino A. J Clin Microbiol; 2004 Apr 07; 42(4):1491-7. PubMed ID: 15070994 [Abstract] [Full Text] [Related]
80. Development of a PCR probe test for identifying Pseudomonas aeruginosa and Pseudomonas (Burkholderia) cepacia. O'Callaghan EM, Tanner MS, Boulnois GJ. J Clin Pathol; 1994 Mar 07; 47(3):222-6. PubMed ID: 7512994 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]